One out of every eight new cancer cases diagnosed worldwide in 2024 can be traced back to an infection the body never beat.
Quick Take
- A new analysis from the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), found infections caused an estimated 2.3 million new cancer cases worldwide in 2024.
- That works out to about 12% of all new cancer diagnoses globally, according to IARC’s own figures.
- Just four germs, H. pylori bacteria and three viruses, cause more than 90% of these infection-linked cancers.
- IARC says many of these cases are preventable through vaccines, screening, and early treatment.
What The New Global Cancer Data Actually Shows
IARC published the findings in The Lancet Oncology, calling it the most complete picture yet of how infections drive cancer worldwide. Researchers estimated that 2.3 million new cancer cases in 2024, roughly 12% of all cases diagnosed that year, started with an infection the body couldn’t clear. The agency built this estimate using the same global cancer tracking system, GLOBOCAN, that powers most of the world’s cancer statistics.
This isn’t a brand new discovery. IARC has tracked this link for more than a decade. In 2012, the agency put the figure at 2.2 million cases, about 15.4% of cancers that year. The number stayed close to 2.2 million again in 2018. The percentage has drifted down over time mainly because overall cancer diagnoses have climbed faster than infection-linked ones, not because the infection threat shrank.
Four Germs Behind Most Of The Damage
A small lineup of repeat offenders does most of the harm. H. pylori, a stomach bacteria many people carry without knowing it, along with human papillomavirus (HPV), hepatitis B virus, and hepatitis C virus together account for more than 90% of infection-driven cancers. One review tied H. pylori to roughly 850,000 cases, HPV to about 730,000, hepatitis B to 380,000, and hepatitis C to 160,000.
The World Health Organization (WHO) has flagged this pattern before. Its global cancer fact sheet notes that infections like HPV and hepatitis drive close to 30% of cancer cases in low- and lower-middle-income countries, far higher than in wealthier nations. That gap matters because it points to where prevention tools, not just awareness, are needed most urgently.
Why IARC Calls These Cancers Preventable
IARC’s own methodology page is blunt about the stakes. The agency defines this entire category as cancers that “would have been prevented… if all infections had been avoided or successfully treated before they caused cancer”. That’s a population-level statement, not a promise for every single patient, but it’s a powerful one. It means vaccines against HPV and hepatitis B, screening for hepatitis C, and treating H. pylori with antibiotics are not just good medicine. They’re cancer prevention tools, full stop.
Outlets covering the study, including Gavi, Euronews, and Medscape, repeated the same 2.3 million figure and tied it directly to named IARC researchers. That kind of consistent, on-record reporting across independent outlets gives the headline number real staying power rather than leaving it as a one-off press release claim.
Five common infections were linked to 2.3 million new cancers in a single year—nearly one in every eight diagnoses worldwide.
A new analysis in The Lancet Oncology makes the scale hard to ignore.
Infections accounted for about 12% of all cancers diagnosed in 2024, an estimated… pic.twitter.com/NUo0LsyBMg— Carolyn Rockey (@CarolynWRockey) September 30, 2026
The Practical Takeaway For Families
None of this requires exotic medicine. HPV vaccines are already standard pediatric care in most American pediatric offices. Hepatitis B shots have been part of childhood vaccine schedules for decades. Hepatitis C has a cure, not just a treatment, available through a short course of pills. H. pylori infection shows up on a simple breath or stool test and clears with antibiotics. The science here isn’t asking Americans to overhaul their lives. It’s asking them to not skip the basics that are already sitting on the shelf.
What makes this data worth paying attention to isn’t just the scale, 2.3 million cases is a staggering number by itself, but the clarity of the fix. Most cancer causes are tangled messes of genetics, environment, and bad luck. This one has a short list of known culprits and known countermeasures. That’s rare in oncology, and it’s the kind of finding that deserves more attention than a single news cycle.
Sources:
mindbodygreen.com, iarc.who.int, gavi.org, cancer.org, euronews.com, academic.oup.com, cidrap.umn.edu
